Risk Assessment of Hereditary Breast and Ovarian Cancers

Risk Assessment of Hereditary Breast and Ovarian Cancers

Kokilaben Hospital introduces Screening for BRCA 1 and 2 gene mutations for Risk Assessment of Hereditary Breast and Ovarian Cancers.

The test is performed using the latest Next generation Sequencing technique on Miseq Illumina platform.

Anyone with a family history of primary breast cancer and ovarian cancer especially occurring at an early age.

Other indications can include family history of Male Breast Cancer and prostrate or pancreatic cancer.

For further information please contact: Cytogenetics and Molecular Biology section, Laboratory Medicine, Kokilaben Dhirubhai Ambani Hospital

Contact no: +91 22 30970707